Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Multi-omics approaches to parkinsonism: genomic, proteomic, and non-coding RNA perspectives

Anusha S, Gurikar S, Kavyashree SB, Nagaraju S, Raghunathanaidu BD, Ahmed SS.

Mol Biol Rep. 2026 Jun 30;53(1):1053. doi: 10.1007/s11033-026-12161-7.

Home-Based, Virtually Supervised Combined Exercise Intervention in People With Parkinson Disease: Protocol for a Randomized Controlled Trial

Mehta N, Munoz MJ, Allen IE, Tanner CM, Corcos DM, Luthra NS.

JMIR Res Protoc. 2026 Jun 30;15:e97507. doi: 10.2196/97507.

Structural dynamics of α-Synuclein: Multi-scale imaging insights into pathological progression across Synucleinopathies

Yang H, Tian Z, Liu J.

Exp Neurol. 2026 Oct;404:115895. doi: 10.1016/j.expneurol.2026.115895. Epub 2026 Jun 30.

Parkinson's Disease Cell Transplantation Therapy: A New Dawn With Pluripotent Stem Cell-Based Therapy

Nakanishi E, Yamakado H, Sawamoto N, Takahashi J, Takahashi R.

J Neurochem. 2026 Jul;170(7):e70500. doi: 10.1111/jnc.70500.

Pongamol as a multitarget neuroprotective candidate: an integrative analysis of in silico predictions and biological evidence

Preeti, Akanksha, Khurana N.

Nat Prod Res. 2026 Jul 1:1-14. doi: 10.1080/14786419.2026.2694726. Online ahead of print.

From clinical phenotypes to molecular stratification: early differential diagnosis of four-repeat tauopathies

Bernhardt AM, Höglinger GU, Palleis C.

Front Aging Neurosci. 2026 Jun 16;18:1801615. doi: 10.3389/fnagi.2026.1801615. eCollection 2026.

EYE movement abnormalities in Parkinson's disease: optometric screening and rehabilitation

Yadav R, Rastogi D, Kumar S, Chowdhury P, Austin E.

Clin Park Relat Disord. 2026 Jun 18;15:100468. doi: 10.1016/j.prdoa.2026.100468. eCollection 2026.

Infusion-site reactions to foslevodopa/foscarbidopa in Parkinson's disease

Urban V, Schreieder L, Drexler K, Weise D, Haferkamp S.

J Dtsch Dermatol Ges. 2026 Jul 1. doi: 10.1111/ddg.70317x. Online ahead of print.

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study

Tohge R, Kaneko S, Kouda K, Oki M, Asayama S, Hatsuta H, Wate R, Yakushiji Y.

Clin Neuropharmacol. 2026 Jul-Aug 01;49(4):155-160. doi: 10.1097/WNF.0000000000000686. Epub 2026 Apr 17.

Neurobiological after-effects and clinical efficacy of transcranial magnetic stimulation (TMS) in Parkinson's disease: a systematic review

Buonocore A, Vermiglio G, Citro S, Cafaro C, De Luca C, Di Cecca A, Sepe G, Marcello L, Soricelli A, Cavaliere C, Cirillo G.

Brain Struct Funct. 2026 Jul 1;231(6):94. doi: 10.1007/s00429-026-03150-4.

Self-management in neurological disorders: a scoping review of behavior change theories, strategies, contents, and impact

Joseph C, Balogun OJ, Kasser S, Escorpizo R.

Disabil Rehabil. 2026 Jul 1:1-21. doi: 10.1080/09638288.2026.2694102. Online ahead of print.

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease

LeDoux MS.

Neurology. 2026 Jul 28;107(2):e218370. doi: 10.1212/WNL.0000000000218370. Epub 2026 Jul 1.

Urodynamics and what they reveal about autonomic innervation of the lower urinary tract: A narrative review

Yasmin H, Aleksejeva K, Johnston L, Malladi P, Simeoni S, Pakzad M.

Auton Neurosci. 2026 Aug;266:103452. doi: 10.1016/j.autneu.2026.103452. Epub 2026 Jun 23.

Respiratory-swallow training in Parkinson's disease: Effects of a single session on swallowing safety and efficiency with exploratory comparisons of biofeedback

Curtis JA, Lowell ER, Troche MS.

Parkinsonism Relat Disord. 2026 Aug;149:108407. doi: 10.1016/j.parkreldis.2026.108407. Epub 2026 Jun 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias